尿路感染症治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Buy Now

[調査レポート]市場は、2019 年の 91 億 640 万米ドルから、2027 年までに 116 億 1,432 万米ドルに達すると予想されます。 2020 年から 2027 年にかけて 3.2% の CAGR で成長すると推定されています。



市場の成長は、尿路感染症の蔓延、高齢化、尿診断用の新たなコンピューティング技術によるものと考えられます。しかし、新興国での製品認知度の不足と薬剤に伴う影響により、尿路感染症治療市場の成長がある程度妨げられています。



尿路感染症治療の収益性の高い地域市場



< h3>市場に関する洞察

尿路感染症の発生率の増加



女性は男性よりも尿路感染症 (UTI) を発症するリスクが高くなります。尿路感染症を治療せずに放置すると、腎臓に深刻な影響を与えるとともに激しい痛みを引き起こす可能性があります。尿路感染症は、持続的な排尿衝動、炎症、尿の外観の変化、吐き気などの特定の症状を示します。 UTIの有病率の増加は、尿路感染症治療市場の成長を促進する顕著な要因の1つです。たとえば、2020年に米国内科医協会と米国感染症学会の研究者グループが実施した研究によると、米国では毎年約600万人の医師が尿路感染症を患っているという。



性行為、不衛生、加齢などの特定の危険因子が尿路感染症を引き起こす可能性があります。これらの危険因子の発生率の増加も、2027年までに尿路感染症治療市場の成長を促進すると推定されています。2019年に国際環境研究および公衆衛生ジャーナルに発表された研究によると、冠状動脈疾患( CAD)、慢性腎臓病(CKD)、糖尿病(DM)は尿路感染症を発症する可能性が高くなります。したがって、UTI の高度な疫学がその治療製品の需要を生み出し、最終的に市場の成長を促進します。



薬剤クラスに基づく洞察



薬剤クラスに基づいて、キノロン類セグメントが最大の地位を占めました。 2019年の市場シェア。ただし、ペニシリンとその併用セグメントは、予測期間中に市場で最高の CAGR 4.5% を記録すると予想されます。キノロン市場の今後の成長は、主に医師によって最も一般的に処方されるという事実によるものです。シプロフロキサシン、レボフロキサシン、エノキサシンは、治療に最も広く使用されている薬剤の 1 つです。



尿路感染症治療市場、薬剤クラス別 - 2019 年および 2027 年



適応症に基づく洞察



h3>

尿路感染症治療市場は、適応症別に複雑性尿路感染症と非合併症性尿路感染症に分類されます。複雑性尿路感染症セグメントは、2019年に大きな市場シェアを保持しました。また、このセグメントは、予測期間中に市場でより高い CAGR を記録すると予想されます。



流通チャネルベースの洞察



流通チャネル別の尿路感染症治療市場は、病院薬局、婦人科および泌尿器科クリニック、ドラッグストア、小売薬局、オンラインドラッグストアに分類されます。 2019 年は病院薬局流通チャネルセグメントが市場で最大のシェアを占めましたが、オンラインドラッグストアセグメントは予測期間中に市場で最高の CAGR を記録すると予想されます。



戦略的洞察



< p>尿路感染症治療市場のプレーヤー - 塩野義製薬、塩野義製薬など株式会社。;テバ・ファーマシューティカル・インダストリーズ株式会社;アラガン。とファイザーは、収益と市場での地位を向上させるために、いくつかの有機的および無機的戦略を採用してきました。たとえば、2019 年 4 月、Teva Pharmaceutical Industries Ltd は、米国で VESIcare (コハク酸ソリフェナシン) 錠剤のジェネリック版 5 mg および 10 mg を発売すると発表しました。



尿路感染症治療市場 - by薬物クラス




  • ペニシリンとその組み合わせ

  • キノロン

  • セファロスポリン

  • アミノグリコシド系抗生物質

  • スルホンアミド
  • 栄養補助食品


尿路感染症治療市場 - 適応症別




  • 複雑性尿路感染症

  • 非合併症尿路感染症感染症


尿路感染症治療市場 - 流通チャネル別




  • 病院薬局

  • 婦人科および泌尿器科クリニック

  • 小売薬局およびドラッグ ストア

  • オンライン ドラッグ ストア


尿路感染症治療市場 - 地理別




  • 北米

    • 米国

    • カナダ

    • メキシコ



  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • 英国

    • スペイン

    • その他のヨーロッパ



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア

    • < li>その他のアジア太平洋地域


  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • < li>アラブ首長国連邦
    • 中東およびアフリカの残りの地域



  • 中南米

    • ブラジル

    • アルゼンチン

    • 中南米のその他の地域




会社概要




  • Teva Pharmaceutical Industries Ltd< /li>
  • Sun Pharmaceutical Industries Ltd

  • Mylan NV

  • ALLERGAN

  • Pfizer Inc.

  • Cipla Ltd

  • F.ホフマン・ラ・ロッシュ株式会社

  • シオノギ株式会社

  • アムウェイ

  • デュポン・ニュートリション・アンド・カンパニー生物科学


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Urinary Tract Infection Treatment Market

 

  1. Teva Pharmaceutical Industries Ltd
  2. Sun Pharmaceutical Industries Ltd
  3. Mylan N.V.
  4. ALLERGAN
  5. Pfizer Inc.
  6. Cipla Ltd
  7. F. Hoffmann-La Roche Ltd
  8. Shionogi Inc.
  9. Amway
  10. DuPont Nutrition & Biosciences

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports